U.S. markets closed
  • S&P 500

    4,232.60
    +30.98 (+0.74%)
     
  • Dow 30

    34,777.76
    +229.23 (+0.66%)
     
  • Nasdaq

    13,752.24
    +119.39 (+0.88%)
     
  • Russell 2000

    2,271.63
    +30.21 (+1.35%)
     
  • Crude Oil

    64.82
    +0.11 (+0.17%)
     
  • Gold

    1,832.00
    +16.30 (+0.90%)
     
  • Silver

    27.57
    +0.09 (+0.32%)
     
  • EUR/USD

    1.2168
    +0.0100 (+0.83%)
     
  • 10-Yr Bond

    1.5770
    +0.0160 (+1.02%)
     
  • GBP/USD

    1.3990
    +0.0097 (+0.70%)
     
  • USD/JPY

    108.5820
    -0.5030 (-0.46%)
     
  • BTC-USD

    57,986.41
    +2,018.50 (+3.61%)
     
  • CMC Crypto 200

    1,480.07
    +44.28 (+3.08%)
     
  • FTSE 100

    7,129.71
    +53.54 (+0.76%)
     
  • Nikkei 225

    29,357.82
    +26.45 (+0.09%)
     

Global Vertebroplasty Market to Reach $301.7 Million by 2027

ReportLinker
·11 min read

Abstract: - Global Vertebroplasty Market to Reach $301. 7 Million by 2027. - Amid the COVID-19 crisis, the global market for Vertebroplasty estimated at US$211 Million in the year 2020, is projected to reach a revised size of US$301.

New York, April 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vertebroplasty Industry" - https://www.reportlinker.com/p06033232/?utm_source=GNW
7 Million by 2027, growing at a CAGR of 5.2% over the period 2020-2027.
- The U.S. Market is Estimated at $57.2 Million, While China is Forecast to Grow at 8% CAGR
- The Vertebroplasty market in the U.S. is estimated at US$57.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$62.5 Million by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

- Select Competitors (Total 42 Featured) -

  • Alphatec Spine, Inc.

  • DePuy Synthes (Johnson & Johnson)

  • Globus Medical, Inc.

  • IZI Medial Products

  • Medtronic

  • Merit Medical Systems, Inc.

  • Rontis

  • SPINUS (BMK Global Medical Company)

  • Stryker Corporation

  • Zavation




Read the full report: https://www.reportlinker.com/p06033232/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Vertebroplasty by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Vertebroplasty by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Vertebroplasty by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 4: USA Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 5: USA Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

CANADA
Table 6: Canada Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 7: Canada Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

JAPAN
Table 8: Japan Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 9: Japan Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

CHINA
Table 10: China Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 11: China Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

EUROPE
Table 12: Europe Current & Future Analysis for Vertebroplasty
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 13: Europe Historic Review for Vertebroplasty by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 14: Europe 15-Year Perspective for Vertebroplasty by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

FRANCE
Table 15: France Current & Future Analysis for Vertebroplasty
by Segment - Vertebroplasty - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 16: France Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

GERMANY
Table 17: Germany Current & Future Analysis for Vertebroplasty
by Segment - Vertebroplasty - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 18: Germany Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

ITALY
Table 19: Italy Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 20: Italy Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

UNITED KINGDOM
Table 21: UK Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 22: UK Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

SPAIN
Table 23: Spain Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 24: Spain Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

RUSSIA
Table 25: Russia Current & Future Analysis for Vertebroplasty
by Segment - Vertebroplasty - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 26: Russia Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

REST OF EUROPE
Table 27: Rest of Europe Current & Future Analysis for
Vertebroplasty by Segment - Vertebroplasty - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 28: Rest of Europe Historic Review for Vertebroplasty by
Segment - Vertebroplasty Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

ASIA-PACIFIC
Table 29: Asia-Pacific Current & Future Analysis for
Vertebroplasty by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 30: Asia-Pacific Historic Review for Vertebroplasty by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 31: Asia-Pacific 15-Year Perspective for Vertebroplasty
by Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2012, 2020 & 2027

AUSTRALIA
Table 32: Australia Current & Future Analysis for
Vertebroplasty by Segment - Vertebroplasty - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 33: Australia Historic Review for Vertebroplasty by
Segment - Vertebroplasty Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

INDIA
Table 34: India Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 35: India Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

SOUTH KOREA
Table 36: South Korea Current & Future Analysis for
Vertebroplasty by Segment - Vertebroplasty - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 37: South Korea Historic Review for Vertebroplasty by
Segment - Vertebroplasty Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

REST OF ASIA-PACIFIC
Table 38: Rest of Asia-Pacific Current & Future Analysis for
Vertebroplasty by Segment - Vertebroplasty - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 39: Rest of Asia-Pacific Historic Review for
Vertebroplasty by Segment - Vertebroplasty Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

LATIN AMERICA
Table 40: Latin America Current & Future Analysis for
Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico
and Rest of Latin America Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 41: Latin America Historic Review for Vertebroplasty by
Geographic Region - Argentina, Brazil, Mexico and Rest of Latin
America Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 42: Latin America 15-Year Perspective for Vertebroplasty
by Geographic Region - Percentage Breakdown of Value Sales for
Argentina, Brazil, Mexico and Rest of Latin America Markets for
Years 2012, 2020 & 2027

ARGENTINA
Table 43: Argentina Current & Future Analysis for
Vertebroplasty by Segment - Vertebroplasty - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: Argentina Historic Review for Vertebroplasty by
Segment - Vertebroplasty Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

BRAZIL
Table 45: Brazil Current & Future Analysis for Vertebroplasty
by Segment - Vertebroplasty - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 46: Brazil Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

MEXICO
Table 47: Mexico Current & Future Analysis for Vertebroplasty
by Segment - Vertebroplasty - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 48: Mexico Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

REST OF LATIN AMERICA
Table 49: Rest of Latin America Current & Future Analysis for
Vertebroplasty by Segment - Vertebroplasty - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 50: Rest of Latin America Historic Review for
Vertebroplasty by Segment - Vertebroplasty Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

MIDDLE EAST
Table 51: Middle East Current & Future Analysis for
Vertebroplasty by Geographic Region - Iran, Israel, Saudi
Arabia, UAE and Rest of Middle East Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 52: Middle East Historic Review for Vertebroplasty by
Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of
Middle East Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 53: Middle East 15-Year Perspective for Vertebroplasty by
Geographic Region - Percentage Breakdown of Value Sales for
Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets
for Years 2012, 2020 & 2027

IRAN
Table 54: Iran Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 55: Iran Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

ISRAEL
Table 56: Israel Current & Future Analysis for Vertebroplasty
by Segment - Vertebroplasty - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 57: Israel Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

SAUDI ARABIA
Table 58: Saudi Arabia Current & Future Analysis for
Vertebroplasty by Segment - Vertebroplasty - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 59: Saudi Arabia Historic Review for Vertebroplasty by
Segment - Vertebroplasty Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

UNITED ARAB EMIRATES
Table 60: UAE Current & Future Analysis for Vertebroplasty by
Segment - Vertebroplasty - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 61: UAE Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

REST OF MIDDLE EAST
Table 62: Rest of Middle East Current & Future Analysis for
Vertebroplasty by Segment - Vertebroplasty - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 63: Rest of Middle East Historic Review for
Vertebroplasty by Segment - Vertebroplasty Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

AFRICA
Table 64: Africa Current & Future Analysis for Vertebroplasty
by Segment - Vertebroplasty - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 65: Africa Historic Review for Vertebroplasty by Segment -
Vertebroplasty Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

IV. COMPETITION
Total Companies Profiled: 42
Read the full report: https://www.reportlinker.com/p06033232/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001